Neola Medical’s CEO shares recent company highlights in winter 2025 investor letter
As 2025 draws to a close, Neola Medical reflects on a year shaped by meaningful clinical progress and continued organizational strengthening. During the winter, the company further reinforced its technological and intellectual property foundation, supporting long-term development. Preparations for clinical progression also continued through site visits at leading neonatal intensive care units in the U.S.
“2025 has been a year of important clinical and organizational progress for Neola Medical. With a solid technological and intellectual property foundation, we continue to move forward in both our clinical development and organizational growth,” says CEO Hanna Sjöström.
Read more in the investor letter winter 2025, attached to this press release and available on the company’s website www.neolamedical.com